The MaineHealth Intellectual Property and Business Development Committee is appointed by the Chief Academic Officer with approval from the MaineHealth Chief Executive Officer, MaineHealth President and Maine Medical Center President.
The Committee is responsible for the following:
- Making recommendations on whether and/or how much of MaineHealth resources to invest to support the development of an invention
- When to license, to whom, and for how much: or to sell outright, if possible.
- Whether to take ownership position in a company that will develop/market as part of license fee
VP of Innovation, MaineHealth
Managing Director, Avalon Ventures
Tom Gridley, PhD
Faculty Scientist III, MaineHealth Institute for Research
Former Investor, Goldman Sachs
Dan Nigrin, MD
Chief Information Officer, MaineHealth
Rich Parker, MS, CBET
VP of Business Development, Schivo Medical
Al Swallow III
Chief Financial Officer, MaineHealth
Robert Rubinowitz, CHDA
Sr. Director of Revenue Cycle Business Intelligence, MaineHealth
Entrepreneur & Board of Trustees member, Maine Medical Center & MaineHealth
Alliance Manager, Music Partnerships, MedRhythms, Inc.